The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Total Voting Rights

31 Oct 2019 10:48

RNS Number : 8081R
Osirium Technologies PLC
31 October 2019
 

31 October 2019

Osirium Technologies plc

("Osirium" or the "Company")

 

Total Voting Rights

For the purposes of DTR5.6.1R of the Transparency Directive, the Company notifies the market of the following:

 

As of 31 October 2019, the Company's issued and fully paid share capital consists of 19,495,655 ordinary shares ("Ordinary Shares") with nominal value of 1 pence each, with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. The total number of voting rights in the Company is therefore 19,495,655.

 

The above figure of 19,495,655 should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

 

For further information, please contact:

 

Osirium Technologies plc

+44 (0) 118 324 2444

David Guyatt, Chief Executive Officer

Rupert Hutton, Chief Financial Officer

Martin Kay, Company Secretary

www.osirium.com

Stifel (Nomad and Joint Broker)

+44 (0) 20 7710 7600

Fred Walsh / Neil Shah

Alma (Financial PR)

+44 (0) 20 3405 0205

Hilary Buchanan / Josh Royston / Kieren Breheny

 

 

About Osirium

 

Osirium Technologies plc (AIM: OSI) operates in one of the fastest growing parts of the cybersecurity market and is a leading vendor of Privileged Access Security solutions. Osirium's cloud-based products protect critical IT assets, infrastructure and devices by preventing targeted cyber-attacks from directly accessing Privileged Accounts, removing unnecessary access and powers of Privileged Account users, deterring legitimate Privileged Account users from abusing their roles and containing the effects of a breach if one does happen. 

 

Osirium has defined and delivered what the Directors view as the next generation Privileged Access Management solution. Built on Robotic Automation technology, Osirium's Privileged Task Management module further strengthens Privileged Account security by minimising the cyber-attack surface and delivering an impressive return on investment benefits for customers. Building on Osirium's Privileged Task Management module, in May 2019 Osirium launched "Opus", providing a highly-flexible platform for automating essential IT processes to set a new benchmark in Privileged Process Automation.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to AIM in April 2016. For further information please visit www.osirium.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVREAEEFDLPNFFF

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.